6505--Metolazone Tablets (VA-26-00032237)

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NAC PHARMACEUTICALS (36E797)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36E79726R0016

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents3
The Department of Veterans Affairs (VA), through its National Acquisition Center (NAC) Pharmaceuticals office, has issued a solicitation (Procurement Identifier: 36E79726R0016) for the supply of Metolazone Tablets. This procurement is classified under NAICS code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is further identified by Product Service Code 6505, indicating a focus on pharmaceutical products. The primary objective of this solicitation is to secure a reliable source for Metolazone Tablets, a medication commonly used in the management of hypertension and edema, to support the ongoing healthcare needs of veterans served by the VA. The scope of the procurement encompasses the manufacturing and timely delivery of Metolazone Tablets that meet all applicable federal quality standards and regulatory requirements. The intended outcome is to ensure uninterrupted access to this essential medication across VA healthcare facilities. Key requirements for this opportunity include the ability to manufacture pharmaceutical-grade Metolazone Tablets in compliance with all relevant FDA regulations and VA specifications. Offerors are expected to demonstrate robust quality assurance processes, consistent production capacity, and the capability to fulfill delivery schedules as outlined in the solicitation documents. The solicitation may also include specific packaging, labeling, and distribution requirements to align with VA logistics and patient safety protocols. The contracting activity is managed by the NAC Pharmaceuticals office, a federal entity within the Department of Veterans Affairs. The primary point of contact for this solicitation is Diana Martinez, who can be reached via email at [email protected] for any questions or clarifications regarding the procurement process. This solicitation is currently active, with a posting date of April 22, 2026, and a response deadline set for the same day at 19:04. Interested contractors are encouraged to review the full solicitation and its three attachments, which are available through the official SAM.gov opportunity listing (Opportunity ID: bb1f760ea36047c3aaa4e32b226e04de). The notice does not specify any set-aside requirements or special considerations; therefore, all qualified manufacturers within the pharmaceutical sector are invited to submit proposals. Contractors evaluating this opportunity should ensure their capabilities align with the stringent manufacturing, quality, and delivery standards expected by the VA. This procurement represents a stable and ongoing requirement for Metolazone Tablets, offering potential for a long-term partnership with the Department of Veterans Affairs in support of veteran healthcare.